RU2340345C2 - Схема восполнения эстрогена - Google Patents

Схема восполнения эстрогена Download PDF

Info

Publication number
RU2340345C2
RU2340345C2 RU2005108977/15A RU2005108977A RU2340345C2 RU 2340345 C2 RU2340345 C2 RU 2340345C2 RU 2005108977/15 A RU2005108977/15 A RU 2005108977/15A RU 2005108977 A RU2005108977 A RU 2005108977A RU 2340345 C2 RU2340345 C2 RU 2340345C2
Authority
RU
Russia
Prior art keywords
doses
estrogen
activity
phases
substance exhibiting
Prior art date
Application number
RU2005108977/15A
Other languages
English (en)
Russian (ru)
Other versions
RU2005108977A (ru
Inventor
Роберт КАСПЕР (CA)
Роберт КАСПЕР
Гидеон КОПЕРНИК (IL)
Гидеон КОПЕРНИК
Зеев ШОХАМ (IL)
Зеев ШОХАМ
Original Assignee
Роберт КАСПЕР
Гидеон КОПЕРНИК
Зеев ШОХАМ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Роберт КАСПЕР, Гидеон КОПЕРНИК, Зеев ШОХАМ filed Critical Роберт КАСПЕР
Publication of RU2005108977A publication Critical patent/RU2005108977A/ru
Application granted granted Critical
Publication of RU2340345C2 publication Critical patent/RU2340345C2/ru

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
RU2005108977/15A 2002-08-28 2003-08-28 Схема восполнения эстрогена RU2340345C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US40633102P 2002-08-28 2002-08-28
US60/406,331 2002-08-28

Publications (2)

Publication Number Publication Date
RU2005108977A RU2005108977A (ru) 2005-10-10
RU2340345C2 true RU2340345C2 (ru) 2008-12-10

Family

ID=31978284

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2005108977/15A RU2340345C2 (ru) 2002-08-28 2003-08-28 Схема восполнения эстрогена

Country Status (25)

Country Link
US (1) US8946198B2 (https=)
EP (1) EP1539184B1 (https=)
JP (1) JP2005538150A (https=)
KR (1) KR20050059092A (https=)
CN (1) CN1678324A (https=)
AT (1) ATE345804T1 (https=)
AU (1) AU2003264203A1 (https=)
BR (1) BR0313921A (https=)
CA (1) CA2495330A1 (https=)
CY (1) CY1106019T1 (https=)
DE (1) DE60309895T2 (https=)
DK (1) DK1539184T3 (https=)
ES (1) ES2277139T3 (https=)
HR (1) HRP20050291A2 (https=)
IL (1) IL166585A0 (https=)
MX (1) MXPA05002294A (https=)
NO (1) NO20051545L (https=)
NZ (1) NZ538342A (https=)
PL (1) PL374762A1 (https=)
PT (1) PT1539184E (https=)
RS (1) RS20050184A (https=)
RU (1) RU2340345C2 (https=)
UA (1) UA82851C2 (https=)
WO (1) WO2004019954A1 (https=)
ZA (1) ZA200501274B (https=)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10022384B2 (en) 2011-07-28 2018-07-17 Lipocine Inc. 17-hydroxyprogesterone ester-containing oral compositions and related methods
US11590147B2 (en) 2015-06-22 2023-02-28 Lipocine Inc. 17-hydroxyprogesterone ester-containing oral compositions and related methods

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8617597B2 (en) 2006-07-06 2013-12-31 Bayer Intellectual Property Gmbh Pharmaceutical composition containing a tetrahydrofolic acid
DE102009007771B4 (de) 2009-02-05 2012-02-16 Bayer Schering Pharma Aktiengesellschaft Bukkales Applikationssystem, 17α-Estradiol enthaltend
EP2383279A1 (en) 2011-07-19 2011-11-02 Pantarhei Bioscience B.V. Process for the preparation of estetrol
BR112014012444B1 (pt) 2011-11-23 2021-12-14 Therapeuticsmd, Inc Composição farmacêutica compreendendo estradiol solubilizado, progesterona e um agente de solubilização, bem como usos desta para tratar um sintoma relacionado à menopausa em uma mulher
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
CA2942345C (en) * 2014-03-12 2020-12-01 Warner Chilcott Company, Llc Low-dose estradiol cream
RU2016143081A (ru) 2014-05-22 2018-06-26 Терапьютиксмд, Инк. Натуральные комбинированные гормонозаместительные составы и терапии
MD3310333T2 (ro) 2015-06-18 2020-06-30 Estetra Sprl Unitate de dozare orodispersabilă care conține un component estetrol
RS61777B1 (sr) 2015-06-18 2021-06-30 Estetra Sprl Oralno-disperzibilna tableta koja sadrži estetrol
HUE054589T2 (hu) 2015-06-18 2021-09-28 Estetra Sprl Szájban diszpergálódó esztetrol tartalmú tabletta
CN116077454A (zh) 2015-06-18 2023-05-09 埃斯特拉有限责任公司 含雌四醇组分的口腔分散剂量单位
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
US9931349B2 (en) 2016-04-01 2018-04-03 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition
CA3178291A1 (en) 2016-08-05 2018-04-12 Estetra Srl Method for the management of dysmenorrhea and menstrual pain
TWI801561B (zh) 2018-04-19 2023-05-11 比利時商依思特拉私人有限責任公司 化合物及其用於緩解絕經相關症狀的用途
DK3781171T3 (da) 2018-04-19 2022-05-02 Estetra Srl Sammensætninger og deres anvendelser til lindring af menopause-associerede symptomer
TWI893101B (zh) 2020-04-16 2025-08-11 比利時商埃斯特拉有限責任公司 具有降低之副作用之避孕組成物

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU98100451A (ru) * 1995-06-07 1999-11-27 Сигнус, Инк. Трансдермальный пластырь и способ введения 17-деацетилноргестимата отдельно или в сочетании с эстрогеном
WO2000059577A1 (en) * 1999-03-30 2000-10-12 Jencap Research Ltd. Low dose estrogen interrupted hormone replacement therapy
RU2165259C2 (ru) * 1995-04-08 2001-04-20 Шеринг Акциенгезелльшафт Фармацевтический комбинированный препарат для гормональной контрацепции

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4826831A (en) * 1983-08-05 1989-05-02 Pre Jay Holdings Limited Method of hormonal treatment for menopausal or post-menopausal disorders involving continuous administration of progestogens and estrogens
ES2054784T3 (es) 1987-08-08 1994-08-16 Akzo Nv Un metodo para la fabricacion de un implante.
US4900734A (en) * 1987-08-27 1990-02-13 Maxson Wayne S Novel pharmaceutical composition containing estradiol and progesterone for oral administration
AU630334B2 (en) * 1987-09-24 1992-10-29 Jencap Research Ltd. Hormone preparations for hormone replacement therapy and contraceptive method
US5256421A (en) 1987-09-24 1993-10-26 Jencap Research Ltd. Hormone preparation and method
US5422119A (en) 1987-09-24 1995-06-06 Jencap Research Ltd. Transdermal hormone replacement therapy
US5276022A (en) 1987-09-24 1994-01-04 Jencap Research Ltd. Hormone preparation and method
US5108995A (en) 1987-09-24 1992-04-28 Jencap Research Ltd. Hormone preparation and method
US5382873A (en) 1991-12-04 1995-01-17 U.S. Philips Corporation High-pressure discharge lamp with incandescing metal droplets
US5521166A (en) * 1994-12-19 1996-05-28 Ortho Pharmaceitical Corporation Antiprogestin cyclophasic hormonal regimen
CA2222133C (en) * 1995-06-07 2002-12-24 Cygnus, Inc. Transdermal patch and method for administering 17-deacetyl norgestimate alone or in combination with an estrogen
US6506390B2 (en) * 1996-06-25 2003-01-14 Akzo Nobel Progestogen-anti-progestogen regimens
US6653298B2 (en) * 2000-01-14 2003-11-25 Sterix Limited Composition
DE10100911A1 (de) * 2001-01-11 2002-08-01 Schering Ag Verfahren zur Hormonersatztherapie und dessen Darreichungsform

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2165259C2 (ru) * 1995-04-08 2001-04-20 Шеринг Акциенгезелльшафт Фармацевтический комбинированный препарат для гормональной контрацепции
RU98100451A (ru) * 1995-06-07 1999-11-27 Сигнус, Инк. Трансдермальный пластырь и способ введения 17-деацетилноргестимата отдельно или в сочетании с эстрогеном
WO2000059577A1 (en) * 1999-03-30 2000-10-12 Jencap Research Ltd. Low dose estrogen interrupted hormone replacement therapy

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
реферат базы данных PubMed: Rebar RW et al. Low-dose esterified estrogens (0.3 mg/day): long-term and shorm-term effects on menopausal symptoms and qualite of life in postmenopausal women. Climacteric. 2000 Sep; 3(3):176-82. {on line] PMID: 11910619 [найдено 28.06.2007]. *
ЭНЦИКЛОПЕДИЯ ЛЕКАРСТВ РЛС 2001, с.919 статья «фемостон» Р.Н.М. van de Weijer et al. Отношение женщин к возобновлению у них менструальных кровотечений в результате ЗГТ и приемлемость для них менструальноподобных реакций. Maturitas 30 1998 р.257-263 [найдено 28.06.2007] Найдено из Интернет: <URL: http://hghltd.yandex.com/yandbtm? url=http%3A%2F%2Fwww.climax.ru%2Fdoctors.... *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10022384B2 (en) 2011-07-28 2018-07-17 Lipocine Inc. 17-hydroxyprogesterone ester-containing oral compositions and related methods
US11590147B2 (en) 2015-06-22 2023-02-28 Lipocine Inc. 17-hydroxyprogesterone ester-containing oral compositions and related methods

Also Published As

Publication number Publication date
EP1539184A1 (en) 2005-06-15
RS20050184A (sr) 2007-11-15
CY1106019T1 (el) 2011-04-06
US20060089337A1 (en) 2006-04-27
DE60309895T2 (de) 2007-10-18
RU2005108977A (ru) 2005-10-10
BR0313921A (pt) 2005-07-19
UA82851C2 (en) 2008-05-26
HRP20050291A2 (en) 2005-10-31
MXPA05002294A (es) 2005-09-12
CA2495330A1 (en) 2004-03-11
NO20051545L (no) 2005-03-23
WO2004019954A1 (en) 2004-03-11
ES2277139T3 (es) 2007-07-01
AU2003264203A1 (en) 2004-03-19
DK1539184T3 (da) 2007-03-19
CN1678324A (zh) 2005-10-05
JP2005538150A (ja) 2005-12-15
PT1539184E (pt) 2007-02-28
DE60309895D1 (de) 2007-01-04
ATE345804T1 (de) 2006-12-15
EP1539184B1 (en) 2006-11-22
KR20050059092A (ko) 2005-06-17
NZ538342A (en) 2007-08-31
US8946198B2 (en) 2015-02-03
ZA200501274B (en) 2006-08-30
PL374762A1 (en) 2005-10-31
IL166585A0 (en) 2006-01-15

Similar Documents

Publication Publication Date Title
RU2340345C2 (ru) Схема восполнения эстрогена
US5585370A (en) Hormone preparation and method
US5108995A (en) Hormone preparation and method
RU2139056C1 (ru) Гормональная заместительная терапия
JP3208482B2 (ja) 避妊製剤
RU2245713C2 (ru) Прерывистая гормонозаместительная терапия низкими дозами эстрогена
EP0799043B1 (en) Cyclophasic hormonal regimen containing antiprogestin and progestin
US5256421A (en) Hormone preparation and method
KR20160150113A (ko) 연장된 호르몬성 피임제 투약법에서 파탄성 출혈의 관리
DK174181B1 (da) Farmaceutisk præparat til hormonbehandling
HK1084018A (en) Estrogen replacement regimen
IE84449B1 (en) Contraceptive packages containing oestrogen and progestin

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20090829